Aptorum Group Limited - Class A Ordinary Shares (APM): Price and Financial Metrics

Aptorum Group Limited - Class A Ordinary Shares (APM): $1.40

0.03 (+2.19%)

POWR Rating

Component Grades













APM Stock Summary

  • With a price/sales ratio of 47.5, Aptorum Group Ltd has a higher such ratio than 96.07% of stocks in our set.
  • With a year-over-year growth in debt of -75.7%, Aptorum Group Ltd's debt growth rate surpasses only 3.57% of about US stocks.
  • As for revenue growth, note that APM's revenue has grown 128.34% over the past 12 months; that beats the revenue growth of 93.41% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Aptorum Group Ltd are SPRO, TVTX, PRTC, FBIO, and LCTX.
  • Visit APM's SEC page to see the company's official filings. To visit the company's web site, go to www.aptorumgroup.com.

APM Valuation Summary

  • APM's price/sales ratio is 99.2; this is 2510.53% higher than that of the median Healthcare stock.
  • Over the past 33 months, APM's price/earnings ratio has gone up 76.
  • Over the past 33 months, APM's price/earnings ratio has gone up 76.

Below are key valuation metrics over time for APM.

Stock Date P/S P/B P/E EV/EBIT
APM 2021-08-31 99.2 2.2 14.3 13.7
APM 2021-08-30 96.3 2.1 13.9 13.3
APM 2021-08-27 95.2 2.1 13.8 13.1
APM 2021-08-26 94.0 2.0 13.6 12.9
APM 2021-08-25 92.9 2.0 13.4 12.8
APM 2021-08-24 92.7 2.0 13.4 12.8

APM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • APM has a Quality Grade of C, ranking ahead of 44.63% of graded US stocks.
  • APM's asset turnover comes in at 0.027 -- ranking 360th of 680 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows APM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2020-12-31 0.027 -0.114 0.220
2019-12-31 0.016 -0.485 -0.814

APM Price Target

For more insight on analysts targets of APM, see our APM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $15.00 Average Broker Recommendation 1.5 (Moderate Buy)

APM Stock Price Chart Interactive Chart >

Price chart for APM

APM Price/Volume Stats

Current price $1.40 52-week high $3.24
Prev. close $1.37 52-week low $0.86
Day low $1.36 Volume 174,700
Day high $1.45 Avg. volume 1,377,729
50-day MA $1.17 Dividend yield N/A
200-day MA $1.72 Market Cap 49.90M

Aptorum Group Limited - Class A Ordinary Shares (APM) Company Bio

Aptorum Group Ltd. is a pharmaceutical company, which engages in the development and commercialization of therapeutic and diagnostic technologies. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The Non-Therapeutics segment encompasses the development of surgical robotics and medical devices; and the activities of AML Clinic. The company was founded by Ian Huen on September 13, 2010 and is headquartered in Hong Kong.

APM Latest News Stream

Event/Time News Detail
Loading, please wait...

APM Latest Social Stream

Loading social stream, please wait...

View Full APM Social Stream

Latest APM News From Around the Web

Below are the latest news stories about Aptorum Group Ltd that investors may wish to consider to help them evaluate APM as an investment opportunity.

Aptorum Group: Advancing Oncology, Autoimmune & Infectious Disease Therapies

No summary available.

Seeking Alpha | February 11, 2022

BATL and PALI among mid-day movers

Gainers: BioCardia BCDA +30%.Aptorum Group (APM) +22%.Bon Natural Life BON +17%.Lightning eMotors ZEV +15%.Modine Manufacturing MOD +14%.Battalion Oil (BATL) +13%.DXC

Seeking Alpha | February 3, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Good morning, investor!

William White on InvestorPlace | January 28, 2022

Thinking about buying stock in Aptorum Group, Ford Motor, Nokia, Catalyst Biosciences, or General Electric?

NEW YORK , Jan. 25, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APM, F, NOK, CBIO, and GE. … Full story available on Benzinga.com

Benzinga | January 25, 2022

FMS, GMBL and APM among pre market gainers

Aptorum Group (APM) +39%. Sierra Oncology SRRA +36% says late-stage trial for momelotinib in myelofibrosis met key goals.Checkpoint Therapeutics CKPT +18% reports positive results

Seeking Alpha | January 25, 2022

Read More 'APM' Stories Here

APM Price Returns

1-mo 7.69%
3-mo -11.95%
6-mo -6.67%
1-year -55.27%
3-year -94.11%
5-year N/A
YTD -6.67%
2021 -39.27%
2020 -84.42%
2019 4.41%
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.5921 seconds.